Abstract: One aspect of the invention relates to a sterilized nutritional beverage product comprising: • from 0.5-8.0 wt.% protein; • from 0.1-10 wt.% of dispersed fat; • from 0.2-4.0 wt.% of starch component; • from 0.01-2.0 wt.% of fatty acid emulsifier; • from 0.01-2.5 wt.% of non-dissolved edible salt; • from 0.005-0.5 wt.% of a hydrocolloid selected from the group consisting of carrageenan, guar gum, carboxymethyl cellulose, microcrystalline cellulose and combinations thereof; • from 0-8.0 wt.% of other nutritional components; and • 70-90 wt.% water. The invention provides a sterilised nutritionally balanced beverage, which beverage exhibits excellent stability even when stored for several weeks under tropical conditions. Furthermore, despite the high content of solutes and biopolymers, said beverage produces a pleasant mouthfeel. The invention also provides a process for the manufacture of the aforementioned beverage.
F7902/V
FORM-2
THE PATENTS ACT, 1970
(39 of 1970)
&
The Patents Rules, 2003
COMPLETE SPECIFICATION
(See Section 10 and Rule 13)
NUTRITIONAL BEVERAGE
HINDUSTAN UNILEVER LIMITED, a company incorporated under the Indian Companies Act, 1913 and having its registered office at Hindustan Lever House, 165/166, Backbay Reclamation, Mumbai -400 020, Maharashtra, India
The following specification particularly describes the invention and the manner in which it is to be performed
WO 2007/054274 PCT/EP2006/010675
1
NUTRITIONAL BEVERAGE
TECHNICAL FIELD OF THE INVENTION 5
The present invention relates to a sterilised nutritional beverage containing protein, fat, carbohydrates, non-dissolved salts and water. The present beverage has a pleasant mouthfeel and can be stored under tropical conditions for several weeks
10 without showing signs of destabilisation. In particular, the nutritional beverage of the present invention exhibits exceptional stability against sedimentation, oil separation, flocculation and creaming; Furthermore, also the rheological properties of the beverage do not change significantly during
15 storage under extreme conditions.
BACKGROUND OF THE INVENTION
Nutritional beverages containing protein, fat and carbohydrates 20 and non-dissolved salts are known in the art. During
processing, transportation and storage of these beverages
sedimentation of the non-dissolved salts is likely to occur.
Such sedimentation is undesirable because it adversely affects
the appearance of the product. Furthermore, the sediment is 25 often not consumed, meaning that nutritionally important
minerals (e.g. calcium, iron etc.) that are contained in the
sediment are not ingested.
Another form of instability that can give rise to serious 30 product quality problems is destabilization of the dispersed oil phase. These emulsion stability problems are, for instance, caused by flocculation, creaming and/or coalescence of the dispersed oil droplets. These dynamic phenomena can
WO 2007/054274
2
PCT/EP2006/010675
dramatically affect the appearance and sensory characteristics of the beverages.
Thermodynamically speaking, oil-in-water emulsions are metastable systems which means that they are prepared using excess energy (mechanical in most cases). After a period of time which depends strongly on the preparation method and the product composition, the emulsion eventually phase separates in two phases. The phase separation involves coalescence of the oil droplets which grow as a function of time. This is an irreversible process.
Besides coalescence, oil-in-water emulsions often exhibit other types of destabilisation, notably flocculation and creaming. Flocculation, like coalescence, is a mechanism that involves the coming together of oil droplets. However, in case of flocculation no coalescence is observed, i.e. the oil droplets form aggregates that separate from the bulk. Creaming occurs in oil-in-water emulsions because the density of the oil droplets is lower than that of the continuous aqueous phase into which they have been dispersed. Due to this density difference, there is driving force that gradually moves the oil droplets to the top surface of the product.
As will be clear from the above, it is impossible to completely prevent the occurrence of coalescence, flocculation and creaming in oil-in-water emulsions such as the present nutritional beverage. However, by reducing the rate at which these phenomena occur, sufficient product stability can be achieved to ensure that product quality will remain acceptable throughout the product's shelf-life.
The speed at which coalescence, flocculation and creaming occur
WO 2007/054274 PCT/EP2006/010675
3
in oil-in-water emulsions increases rapidly with temperature increase. Another factor that accelerates these destabilisation phenomena are high solute concentrations in the aqueous phase. Nutritional beverages typically comprise aqueous phases with 5 high solute concentrations due to the presence of substantial levels of proteins and carbohydrates.
Thus, it is a major challenge to provide nutritional beverages in the form of oil-in-water emulsions that can be stored for 10 several weeks under tropical conditions without developing serious stability defects. In order to provide a nutritional beverage that can be stored for several weeks under tropical conditions, before being consumed, it must be ensured that no microbial spoilage occurs during this period. Effectively, this 15 means that the product must be sterilised and packaged under aseptic conditions. Since sterilisation conditions favour coalescence of oil droplets, the product needs to be formulated in such a way that coalescence of oil droplets and sedimentation of non-dissolved salts is not only prevented 20 during storage and handling under tropical conditions, but also during sterilisation.
In order to minimise one or more of the aforementioned destabilization phenomena, it has been suggested in the prior
25 art to employ thickening agents, emulsifiers etc. These
ingredients affect the rheological properties of the product, e.g. the viscosity. However, during storage, especially under tropical conditions, the rheological properties of beverages containing these thickening agents and/or emulsifiers tend to
30 change quite noticeably. Often, the viscosity of the product increases in time until it reaches an unacceptable level. In some instances, beverages were actually found to form a gel during storage. These changes in rheological properties are
WO 2007/054274 PCTVEP2006/010675
4
believed to result from dynamic interactions between thickening agents and emulsifiers or by interactions of these ingredients with other ingredients of the beverage.
5 US 6,475,539 describes a shelf stable liquid enteral formula having a pH of from about 3.0-4.6 comprising:
(a) from about 45-95% by weight water;
(b) from about 1.0-15% by weight of caseinate
(c) from 0.5-3.3% by weight of high methoxy pectin; 10 (d) from about 1-30% by weight of a carbohydrate;
(e) from about 0.5-10% by weight of an edible oil;
(f) sufficient quantities of protein, carbohydrate, and edible
oil to serve as a sole source of nutrition, in a volume ranging
from 1000-2000 ml,
15 (g) at least 100% of the adult RDI for vitamins and minerals,
in a volume ranging from 1000-2000 ml, and;
(h) and said enteral formula has a shelf life of at least one
year. The carbohydrate is preferably selected from the group
consisting of dextrose, lactose, fructose, sucrose, maltose, 20 corn starch, hydrolysed corn starch, maltodextrin, glucose
polymers, corn syrup solids, oligosaccharides, high
saccharides, high fructose corn syrup, and
fructooligosaccharides. It is observed in the US patent that
one aspect of the invention described therein relates to 25 process of manufacture which produces a beverage with excellent
physical stability even after retort sterilisation, aseptic
packaging and hot-fill processes.
It is an objective of the present invention to provide a 30 sterilised nutritionally balanced beverage that contains protein, carbohydrates, fat and non-dissolved salts, which beverage exhibits excellent stability even when stored for several weeks under tropical conditions. Furthermore, it is an
WO 2007/054274
5
PCT/EP2006/010675
objective to provide a sterilised beverage that, despite the high content of solutes and biopolymers, produces a pleasant mouthfeel.
5
SUMMARY OF THE INVENTION
The present inventors have realised these objectives by developing a carefully balanced formulation. More particularly, 10 the inventors have provided a nutritional beverage containing:
a) from 0.5-8.0 wt.% protein;
b) from 0.1-10 wt.% of dispersed fat;
c) from 0.2-4 wt.% of starch component selected from the group consisting of native starch, modified starch and
15 combinations thereof;
d) from 0.01-2.0 wt.% of fatty acid emulsifier;
e) from 0.01-2.5 wt.% of non-dissolved edible salt;
f) from 0.005-0.5 wt.% of a hydrocolloid selected from the group consisting of carrageenan, guar gum, carboxymethyl
20 cellulose, microcrystalline cellulose and combinations thereof;
g) from 0-8.0 wt.% of other nutritional components; and
h) 70-90 wt.% water.
25 Although the inventors do not wish to be bound by theory, it is believed that the combination of starch component, fatty acid emulsifier and hydrocolloid fulfils a critical role in stabilising the present nutritional product against sedimentation of the non-dissolved salt. Furthermore, this
30 combination provides exceptional emulsion stability despite the fact that the present beverages contain high levels of solute. Moreover, although the aforementioned combination of ingredients can render the present beverage rather viscous, the
WO 2007/054274
6
PCT/EP2006/010675
viscosity and other rheological parameters of the product remain stable irrespective of the temperature at which the product is stored. Finally, the present product has a very pleasant mouthfeel, despite the fact that it contains high 5 levels of solutes, biopolymer and even non-dissolved salts.
The present invention also provides a method of manufacturing such a nutritional beverage as described above, said method comprising:
10 • combining the protein, fat, starch component, fatty acid
emulsifier, hydrocolloid, non-dissolved salt, optional other nutritional components and water in a pre-emulsion;
• homogenising the pre-emulsion; and
• sterilising the homogenised pre-emulsion by heating it to a 15 temperature of more than 130°C for 2-30 seconds.
DETAILED DESCRIPTION OF THE INVENTION
20 Accordingly, one aspect of the invention relates to a sterilized nutritional beverage product comprising:
a) from 0.5-8.0 wt.%, preferably from 1.0-6.0 wt.% protein;
b) from 0.1-10 wt.%, preferably from 1.0-6.0 wt.% of dispersed fat;
25 c) from 0.2-4.0 wt.%, preferably from 0.5-3.0 wt.% of starch component selected from the group consisting of native starch, modified starch and combinations thereof; d) from 0.01-2.0 wt.%, preferably from 0.05-1.2 wt.% of fatty acid emulsifier; 30 e) from 0.01-2.5 wt.%, preferably from 0.05-1.0 wt.% of non-dissolved edible salt; f) from 0.005-0.5 wt.%, preferably from 0.01-0.3 wt.% of a hydrocolloid selected from the group consisting of
WO 2007/054274
7
PCT/EP2006/010675
carrageenan, guar gum, carboxymethyl cellulose, macrocrystalline cellulose and combinations thereof; g) from 0-8.0 wt. % of other nutritional components; and h) 70-90 wt.% water. 5
The terms "fat" and "oil" as used herein are synonyms and refer to triglycerides.
The term "native starch" as used herein refers to a starch that 10 has been isolated from a natural plant source and that has not been hydrolysed or chemically modified.
The term "modified starch" refers to a starch that has been chemically modified, e.g. by esterification. The term "modified 15 starch" does not encompass starches that have been altered exclusively by means of hydrolysis. Thus, neither the term "native starch" nor the term "modified starch" encompasses hydrolysed starches such as maltodextrins.
20 The term "fatty acid emulsifier" refers to an emulsifier that contains at least one fatty acid residue, especially at least on fatty acid residue with a carbon chain length of at least 8 carbon atoms.
25 The terminology "non-dissolved salt" refers to salts that are present in the nutritional beverage in non-dissolved form. In order to prevent sedimentation, these non-dissolved salts need to be kept suspended in the beverage.
30 The combination of protein, carbohydrate and fat, typically
represents at least 6 wt.%, preferably at least 8 wt.% and most preferably at least 10 wt.% of the present nutritional beverage.
WO 2007/054274
8
PCT/EP2006/010675
According to a particularly preferred embodiment, the present beverage product contains at least 0.1 wt.%, more preferably at least 0.2 wt.% and most preferably at least 0.3 wt.% of fatty 5 acid emulsifier.
Examples of fatty acid emulsifiers that may advantageously be employed in the present beverage include monoglycerides, diglycerides, esters of monoglycerides and food acids, esters 10 of monoglycerides and food acids and combinations of these emulsifiers. Examples of suitable food acids include citric acid and tartaric acid.
According to a particularly preferred embodiment, the fatty 15 acid emulsifier is selected from the group consisting of monoglycerides, diglycerides and combinations thereof.
In accordance with another preferred embodiment, the fatty acid emulsifier has an iodine value of less than 12, more preferably
20 of less than 6. Although the inventors do not wish to be bound by theory, it is believed that emulsifiers containing saturated fatty acid residues, especially saturated monoglycerides, can form stable complexes with the starch component, thus preventing, for instance, amylose retrogradation. Amylose
25 retrogradation is inevitably accompanied by viscosity changes.
Typically, the emulsifiers employed in the present product have an HLB of 1-12. Particularly good stability can be achieved if the fatty acid emulsifier contained in the present beverage has 30 an HLB of 3-10.
The hydrocolloids employed in the present beverage helps to prevent sedimentation of the non-dissolved salt. It was found
WO 2007/054274
9
PCT/EP2006/010675
that carrageenan is particularly effective in preventing salt sedimentation. Hence, in a preferred embodiment, the hydrocolloid is carrageenan. Preferably, carrageenan is incorporated in a concentration of 0.01-0.2 wt.%. Carrageenan 5 is a complex carbohydrate extracted from red seaweed and is believed to provide stability in the present nutritional beverage through interaction with the protein, causing the formation of very weak thixotropic gels at low concentrations.
10 The non-dissolved edible salt is suitably selected from the group consisting of iron salts, calcium salts, zinc salts and combinations thereof. According to a particularly preferred embodiment, the non-dissolved salt is selected from the group consisting of iron-fumarate, iron pyrophosphate, calcium
15 phosphate, calcium carbonate and combinations thereof.
Examples of modified starches that may suitably be incorporated in the present beverage include esterified starches, crosslinked starches, oxidised starches, succinate modified
20 starches and pregelatinised starches and combinations of these modified starches. It should be understood that the present invention also encompasses the use of starches that have undergone multiple modifications, e.g. crosslinked hydroxyalkylated starches. Typical examples of esterified
25 starches include acetylated, hydroalkylated, phosphorylated and succinated starches. Most preferably, the modified starch is a cross-linked or esterified starch.
The native starch applied in the present nutritional beverage 30 may be obtained from various plant sources known in the art, such as potato, tapioca and maize. Preferably, the native starch is a native maize starch. Most preferably, the native starch is a native waxy maize starch.
WO 2007/054274 PCT7EP2006/010675
10
The pH of the present beverage product can vary within a broad range, e.g. between 3.0 and 7.5. Preferably, the pH of the beverage product is within the range of 4.7-8.0, most 5 preferably of 5.0-7.5. The problems associated with the presence of non-dissolved salts are generally much less pronounced in low pH products. Hence, the advantages of the present invention are particularly pronounced in non-acidified or slightly acidified beverage products. 10
The exceptional stability of the present beverage is also believed to be associated with the combined use of protein and starch component in the indicated concentrations. Particularly good results have been obtained if the protein employed is 15 dairy protein. Examples of suitable sources of dairy protein include milk, whey, skim milk, cheese, curd, casein, caseinate. Preferably, the present composition contains a source of dairy protein selected from the group consisting of milk, whey, skim milk, casein, caseinate and combinations thereof. These 20 materials may be incorporated in the present beverage in dehydrated or liquid form, preferably in dehydrated, e.g. powder form. The protein content of the present beverage preferably is at least 1 wt.%, more preferably at least 2 wt.%, most preferably at least 3 wt.%. 25
According to a particularly preferred embodiment of the invention the nutritional beverage comprises 0.1-2 wt.% caseinate, e.g. sodium caseinate. The incorporation of caseinate in the indicated amounts was found to effectively 30 stabilise the beverage against coalescence during sterilisation and storage.
The carbohydrates contained in the present beverage preferably
WO 2007/054274
11
PCT7EP2006/010675
include saccharides selected from the group consisting of monosaccharides, disaccharides and combinations thereof. Typically, the amount of saccharides contained in the present beverage is within the range of 0-10 wt.%, preferably within 5 the range of 3-6 wt.%.
In addition, the present beverage may suitably contain maltodextrin, e.g. in an amount of 0-10% by weight of the beverage. Particularly suitable maltodextrins have a DE in the 10 range of 2 to 20. Preferably, the maltodextrin employed in the present beverage has a DE in the range of 10 to 20.
As explained herein before, the incorporation of high levels of carbohydrates favours physical destabilisation of the nutrional 15 beverage. Nonetheless, it was found that stable beverages can be prepared in accordance with the present invention even if these beverages contain at least 6 wt.% or even at least 9 wt.% of carbohydrates.
20 The nutritional beverage of the present invention is a pourable product. Typically, the present beverage has a viscosity (at 20 °C) in the range of 5-200 mPa.s at 10 s-1. More preferably, the present beverage has a viscosity in the range of 10-100 mPa.s at 10 s-1, most preferably of 10-50 mPa.s, meaning that the
25 product is a thin liquid that can easily be swallowed. The viscosity of the present beverage is suitably determined by means of a Rheometer ® AR1000, using a shear rate sweep from 0.01 to 250 s-1 (in 510 s.) and a cone plate measuring system with a cone angle 2:0:38 (deg:min:sec), a cone diameter of 40
30 mm and a truncation of 54 microns.
The nutritional beverage of the present invention advantageously contains one or more minerals, especially
WO 2007/054274 PCT/EP2006/010675
12
transition metals such as iron and zinc. Typically, the beverage contains at least 10 ppm of iron and/or zinc cations. Preferably, the beverage contains at least 10 ppm iron cations, more preferably at least 20 ppm iron cations. The content of 5 iron cations usually does not exceed 200 ppm, preferably it does not exceed 100 ppm.
Other nutritional components, besides minerals, that may advantageously be incorporated in the present beverage include 10 vitamins, sterols, flavonoids, carotenoids etc.
The fat contained in the present beverage preferably is a liquid non-hydrogenated oil containing at least 60% unsaturated fatty acid residues by weight of the total amount of fatty acid 15 residues contained in said oil. Examples of suitable liquid oils include vegetable oils (sunflower oil, soybean oil, safflower oil etc.) and fish oils.
As explained herein before, the present beverage is an oil-in-20 water emulsion. The fat is preferably present in said beverage with a as dispersed droplets with an average diameter D3.2 of 0.1-3 µm, preferably of 0.3-2 µ m. The average diameter D3.2 (i.e. the surface weighted average diameter) can suitably be determined by means of laser diffraction, using a Helos ™ laser 25 diffraction sensor (ex Sympatec GmbH) in combination with a 632.8 nm laser. Measurements are conducted at 20 °C using a QUIXEL ™ wet dispenser ex Sympatec GmbH (at an optical concentration between 10 and 20%).
30 Typically, the excellent storage stability of the present beverage is evidenced by an increase of the average diameter D3.2 of less than 50% when the beverage is stored at 40°C for one month. Under these severe storage conditions an increase of
WO 2007/054274 PCT/EP2006/010675
13
the average diameter D3,2 of less than 200% can readily be achieved in the present nutritional beverage. Preferably, the increase in D3.2 observed under these conditions does not exceed 100%, more preferably it does not exceed 80%, most preferably 5 it does not exceed 60%.
The caloric content of the present nutritional beverage typically is in the range of 0.4-1.7 kcal/ml. Most preferably, the caloric content is in the range of 0.7-1.3 kcal/ml. Of the
10 total caloric content, preferably not more than 40% is provided by fat. Preferably, fat represents between 25 and 35% of the total caloric content of the beverage. Typically, carbohydrates and proteins provide between 35-67%, respectively 10-33% of the total caloric content of the beverage.
15
Another aspect of the invention relates to a process of manufacturing a sterilised nutritional beverage, said method comprising:
• combining the protein, fat, starch component, fatty acid
20 emulsifier, hydrocolloid, non-dissolved salt, optional other nutritional components and water in a pre-emulsion;
• homogenising the pre-emulsion; and
• sterilising the homogenised pre-emulsion by heating it to a temperature of more than 130°C for 2-30 seconds.
25
The aforementioned sterilisation conditions are typical of so called ultra high temperature (UHT) sterilisation. UHT sterilisation may suitably be achieved in the present method by either direct or indirect heating.
30
It is important that homogenisation of the pre-emulsion yields an emulsion with very fine oil droplets. Preferably, the oil droplets in the homogenised pre-emulsion exhibit a mean
WO 2007/054274 PCT/EP2006/010675
14
diameter D3.2 of 0.1-3 µ m preferably of 0.3-2 µm. Typically, homogenisation is achieved in the present method at a pressure of at least 8 Mpa. Preferably, the pre-emulsion is homogenised at a pressure in the range. of 10-30 Mpa.
The invention is further illustrated by means of the following examples.
WO 2007/054274 PCT/EP2006/010675
15
EXAMPLES
Example 1
A nutrional beverage was prepared on the basis of the following 5 recipe:
Ingredient Wt.%
Skim milk powder 5.0
Sodium caseinate 0.36
Dipotassium phosphate 0.185
Fat 2.18
Mono/diglycerides (Cremodan Super, Danisco) 0.15
Sucrose 5.0
Native starch (Waxilys 200 ex Roquette) 1.0
Carrageenan (CL110, Danisco) 0.025
Iron fumarate 0.016
Zinc sulphate 0.008
V/M premix (containing 95.5 wt. % Na-ascorbate) 0.107
Water Remainder [
The water was weighed and heated to 80°C. Skimmed milk powder was pre-mixed with potassium phosphate and mono/di-glycerides. This mixture was dispersed in the hot water under high speed
10 mixing and hydrated under proper mixing for 15 minutes. An oil blend containing 0.95% DHA was produced using Soybean oil and a DHA concentrate based on Algae oil ex Nutrinova in a ratio of 97.8:2.2%. This oil mixture was added under high speed mixing and pre-emulsified by proper mixing for 15 minutes. Next, the
15 maltodextrin, the native starch and carrageenan was dispersed in this pre-emulsion
A blend containing vitamin C, iron salt, zinc salt and V/M premix was added to the pre-emulsion, followed by the sugar. 2 0 The pH was checked and corrected whenever it was below < 6.7 using phosphate buffer. The product was homogenised at 175 -250 bar and 65-70°C and thereafter UHT treated at 140°C - 4
WO 2007/054274 PCT/EP2006/010675
16
sec. Thereafter the product was cooled to 25-30°C and filled aseptically in PET bottles (250 ml) with a screw cap.
The emulsion so prepared was stored at 40°C for 4 months. 5 Slight creaming was observed in these samples after this storage period.
WO 2007/054274
PCT/EP2006/010675
17 Claims
1. A sterilized nutritional beverage product comprising:
a) from 0.5-8.0 wt.% protein;
b) from 0.1-10 wt.% of dispersed fat;
c) from 0.2-4 wt.% of starch component selected from the group consisting of native starch, modified starch and combinations thereof;
d) from 0.01-2.0 wt.% of fatty acid emulsifier;
e) from 0.01-2.5 wt.% of non-dissolved edible salt;
f) from 0.005-0.5 wt.% of a hydrocolloid selected from the group consisting of carrageenan, guar gum, carboxymethyl cellulose, microcrystalline cellulose and combinations thereof;
g) from 0-9.0 wt.% of other nutritional components; and
h) 70-90 wt.% water.
2. Nutritional beverage according to claim 1, wherein the fatty acid emulsifier is selected from the group consisting of monoglycerides, diglycerides, esters of monoglycerides and food acids, esters of monoglycerides and food acids and combinations thereof.
3. Nutritional beverage according to claim 1 or 2, wherein the fatty acid emulsifier is selected from the group consisting of monoglycerides, diglycerides and combinations thereof,
4. Nutritional beverage according to any one of the preceding claims, wherein the fatty acid emulsifier has an iodine value of less than 12.
5. Nutritional beverage according to any one of the preceding
WO 2007/054274
PCT7EP2006/010675
18 claims wherein the hydrocolloid is carrageenan.
6. Nutritional beverage according to any one of the preceding claims, wherein the non-dissolved edible salt is selected from the group consisting of iron salts, calcium salts, zinc salts and combinations thereof.
7. Nutritional beverage according to any one of the preceding claims, said beverage having a viscosity (at 20 °C) in the range of 5-200 mPa.s at 10 s"1.
8. Nutritional beverage according to any one of the preceding claims, wherein the fat is present as dispersed droplets with a diameter D3,2 of 0.1-3 µm, preferably of 0.3-2 µm.
9. Nutritional beverage according to any one of the preceding claims, having a pH in the range of 4.7-8.0.
10. A process of manufacturing a sterilised nutritional
beverage according to any one of the preceding claims, said
method comprising:
• combining the protein, fat, starch component, fatty acid emulsifier, hydrocolloid, non-dissolved salt, optional other nutritional components and water in a pre-emulsion;
• homogenising the pre-emulsion; and
• sterilising the homogenised pre-emulsion by heating it to a temperature of more than 130°C for 2-30 seconds.
Dated this 8th day of May 2008
HINDUSTAN UNILEVER LIMITED
(S. Venkatramani) Senior Patents Manager
WO 2007/054274
PCT/EP2006/010675
17 Claims
1. A sterilized nutritional beverage product comprising:
a) from 0.5-8.0 wt.% protein;
b) from 0.1-10 wt.% of dispersed fat;
c) from 0.2-4 wt.% of starch component selected from the group consisting of native starch, modified starch and combinations thereof;
d) from 0.01-2.0 wt.% of fatty acid emulsifier;
e) from 0.01-2.5 wt.% of non-dissolved edible salt;
f) from 0.005-0.5 wt.% of a hydrocolloid selected from the group consisting of carrageenan, guar gum, carboxymethyl cellulose, microcrystalline cellulose and combinations thereof;
g) from 0-9.0 wt.% of other nutritional components; and
h) 70-90 wt.% water.
2. Nutritional beverage according to claim 1, wherein the fatty acid emulsifier is selected from the group consisting of monoglycerides, diglycerides, esters of monoglycerides and food acids, esters of monoglycerides and food acids and combinations thereof.
3. Nutritional beverage according to claim 1 or 2, wherein the fatty acid emulsifier is selected from the group consisting of monoglycerides, diglycerides and combinations thereof,
4. Nutritional beverage according to any one of the preceding claims, wherein the fatty acid emulsifier has an iodine value of less than 12.
5. Nutritional beverage according to any one of the preceding
WO 2007/054274
PCT7EP2006/010675
18 claims wherein the hydrocolloid is carrageenan.
6. Nutritional beverage according to any one of the preceding claims, wherein the non-dissolved edible salt is selected from the group consisting of iron salts, calcium salts, zinc salts and combinations thereof.
7. Nutritional beverage according to any one of the preceding claims, said beverage having a viscosity (at 20 °C) in the range of 5-200 mPa.s at 10 s"1.
8. Nutritional beverage according to any one of the preceding claims, wherein the fat is present as dispersed droplets with a diameter D3i2 of 0.1-3 µm, preferably of 0.3-2 µm.
9. Nutritional beverage according to any one of the preceding claims, having a pH in the range of 4.7-8.0.
10. A process of manufacturing a sterilised nutritional
beverage according to any one of the preceding claims, said
method comprising:
• combining the protein, fat, starch component, fatty acid emulsifier, hydrocolloid, non-dissolved salt, optional other nutritional components and water in a pre-emulsion;
• homogenising the pre-emulsion; and
• sterilising the homogenised pre-emulsion by heating it to a temperature of more than 130°C for 2-30 seconds.
Dated this 8th day of May 2008
HINDUSTAN UNILEVER LIMITED
(S. Venkatramani) Senior Patents Manager
| # | Name | Date |
|---|---|---|
| 1 | 928-mumnp-2008-claims.doc | 2018-08-10 |
| 1 | 928-MUMNP-2008-FORM 2(TITLE PAGE)-(GRANTED)-(17-10-2011).pdf | 2011-10-17 |
| 2 | 928-mumnp-2008-claims.pdf | 2018-08-10 |
| 2 | 928-MUMNP-2008-FORM 2(GRANTED)-(17-10-2011).pdf | 2011-10-17 |
| 3 | 928-MUMNP-2008-DESCRIPTION(GRANTED)-(17-10-2011).pdf | 2011-10-17 |
| 3 | 928-MUMNP-2008-CORRESPONDENCE(25-8-2009).pdf | 2018-08-10 |
| 4 | 928-MUMNP-2008-CORRESPONDENCE(IPO)-(17-10-2011).pdf | 2011-10-17 |
| 4 | 928-mumnp-2008-correspondence(8-5-2008).pdf | 2018-08-10 |
| 5 | 928-mumnp-2008-correspondence.pdf | 2018-08-10 |
| 5 | 928-MUMNP-2008-CLAIMS(GRANTED)-(17-10-2011).pdf | 2011-10-17 |
| 6 | 928-mumnp-2008-wo international publication report(8-5-2008).pdf | 2018-08-10 |
| 7 | 928-mumnp-2008-wo international publication report a1.pdf | 2018-08-10 |
| 7 | 928-mumnp-2008-description(complete).pdf | 2018-08-10 |
| 8 | 928-MUMNP-2008-GENERAL POWER OF ATTORNEY(8-5-2008).pdf | 2018-08-10 |
| 8 | 928-mumnp-2008-form 1.pdf | 2018-08-10 |
| 9 | 928-MUMNP-2008-FORM 18(25-8-2009).pdf | 2018-08-10 |
| 9 | 928-mumnp-2008-form-pct-pea-416.pdf | 2018-08-10 |
| 10 | 928-mumnp-2008-form 2(title page).pdf | 2018-08-10 |
| 10 | 928-mumnp-2008-form-pct-pea-409.pdf | 2018-08-10 |
| 11 | 928-mumnp-2008-form-pct-isa-210.pdf | 2018-08-10 |
| 12 | 928-mumnp-2008-form 2.pdf | 2018-08-10 |
| 12 | 928-mumnp-2008-form 5.pdf | 2018-08-10 |
| 13 | 928-MUMNP-2008-FORM 3(24-2-2010).pdf | 2018-08-10 |
| 13 | 928-mumnp-2008-form 5(8-5-2008).pdf | 2018-08-10 |
| 14 | 928-mumnp-2008-form 3(8-5-2008).pdf | 2018-08-10 |
| 14 | 928-mumnp-2008-form 3.pdf | 2018-08-10 |
| 15 | 928-mumnp-2008-form 3(8-5-2008).pdf | 2018-08-10 |
| 15 | 928-mumnp-2008-form 3.pdf | 2018-08-10 |
| 16 | 928-MUMNP-2008-FORM 3(24-2-2010).pdf | 2018-08-10 |
| 16 | 928-mumnp-2008-form 5(8-5-2008).pdf | 2018-08-10 |
| 17 | 928-mumnp-2008-form 5.pdf | 2018-08-10 |
| 17 | 928-mumnp-2008-form 2.pdf | 2018-08-10 |
| 18 | 928-mumnp-2008-form-pct-isa-210.pdf | 2018-08-10 |
| 19 | 928-mumnp-2008-form 2(title page).pdf | 2018-08-10 |
| 19 | 928-mumnp-2008-form-pct-pea-409.pdf | 2018-08-10 |
| 20 | 928-MUMNP-2008-FORM 18(25-8-2009).pdf | 2018-08-10 |
| 20 | 928-mumnp-2008-form-pct-pea-416.pdf | 2018-08-10 |
| 21 | 928-mumnp-2008-form 1.pdf | 2018-08-10 |
| 21 | 928-MUMNP-2008-GENERAL POWER OF ATTORNEY(8-5-2008).pdf | 2018-08-10 |
| 22 | 928-mumnp-2008-description(complete).pdf | 2018-08-10 |
| 22 | 928-mumnp-2008-wo international publication report a1.pdf | 2018-08-10 |
| 23 | 928-mumnp-2008-wo international publication report(8-5-2008).pdf | 2018-08-10 |
| 24 | 928-MUMNP-2008-CLAIMS(GRANTED)-(17-10-2011).pdf | 2011-10-17 |
| 24 | 928-mumnp-2008-correspondence.pdf | 2018-08-10 |
| 25 | 928-mumnp-2008-correspondence(8-5-2008).pdf | 2018-08-10 |
| 25 | 928-MUMNP-2008-CORRESPONDENCE(IPO)-(17-10-2011).pdf | 2011-10-17 |
| 26 | 928-MUMNP-2008-DESCRIPTION(GRANTED)-(17-10-2011).pdf | 2011-10-17 |
| 26 | 928-MUMNP-2008-CORRESPONDENCE(25-8-2009).pdf | 2018-08-10 |
| 27 | 928-MUMNP-2008-FORM 2(GRANTED)-(17-10-2011).pdf | 2011-10-17 |
| 27 | 928-mumnp-2008-claims.pdf | 2018-08-10 |
| 28 | 928-MUMNP-2008-FORM 2(TITLE PAGE)-(GRANTED)-(17-10-2011).pdf | 2011-10-17 |